We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

62 hedge funds and large institutions have $14.6M invested in Genocea Biosciences, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 14

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

2% more funds holding

Funds holding: 61 → 62 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

84% less capital invested

Capital invested by funds: $88.7M → $14.6M (-$74.2M)

100% less call options, than puts

Call options by funds: $1K | Put options by funds: $242K

Holders
62
Holders Change
+1
Holders Change %
+1.64%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
20
Reduced
14
Closed
10
Calls
$1K
Puts
$242K
Net Calls
-$241K
Net Calls Change
-$173K

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$963K
2
QOP
Quinn Opportunity Partners
Virginia
+$584K
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$514K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$436K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$210K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16M
2
Franklin Resources
Franklin Resources
California
-$15.6M
3
RSCM
Rock Springs Capital Management
Maryland
-$2.51M
4
NC
Northpointe Capital
Michigan
-$2.43M
5
Principal Financial Group
Principal Financial Group
Iowa
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
PVMCV
1
Polaris Venture Management Co V
Massachusetts
$2.87M – – –
BlackRock
2
BlackRock
New York
$2.13M +$124K +3,278 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.39M +$436K +11,486 +11%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1.32M -$16M -421,502 -79%
NC
5
Northpointe Capital
Michigan
$1.2M -$2.43M -64,061 -38%
Axa
6
Axa
France
$844K -$37.3K -984 -1%
SFM
7
Sphera Funds Management
Israel
$715K – – –
State Street
8
State Street
Massachusetts
$546K +$32.7K +862 +2%
Northern Trust
9
Northern Trust
Illinois
$446K -$5.31K -140 -0.4%
AA
10
AlphaMark Advisors
Kentucky
$445K – – –
VF
11
Virtu Financial
New York
$296K +$963K +25,363 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$288K +$19.7K +520 +2%
BCM
13
Bridgeway Capital Management
Texas
$220K – – –
QOP
14
Quinn Opportunity Partners
Virginia
$180K +$584K +15,388 New
Balyasny Asset Management
15
Balyasny Asset Management
Illinois
$158K +$514K +13,548 New
Bank of New York Mellon
16
Bank of New York Mellon
New York
$125K +$7.25K +191 +2%
TCIM
17
TIAA CREF Investment Management
New York
$116K +$9.03K +238 +2%
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$88K – – –
TA
19
Teachers Advisors
New York
$75K – – –
Charles Schwab
20
Charles Schwab
California
$72K – – –
GCP
21
GSA Capital Partners
United Kingdom
$72K +$143K +3,763 +157%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$69K -$17.1K -450 -7%
Morgan Stanley
23
Morgan Stanley
New York
$68K +$29.6K +780 +15%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$65K +$210K +5,530 New
BC
25
Birchview Capital
Vermont
$57K – – –
1
2 3

GNCA Hedge Fund Activity: Q3 2017 in Review

62 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q3 2017, worth a combined $14.6M — down 84% from $88.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new GNCA positions and 10 closed out — a net gain of 2 holders — while 20 added to existing stakes and 14 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $963K. The largest seller was Fidelity Investments, cutting an estimated $16M.

  • 62 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q3 2017, up from 61 in Q2 2017.
  • Funds reported $14.6M of Genocea Biosciences, Inc. stock for Q3 2017, down 84% quarter-over-quarter.
  • 12 funds opened new Genocea Biosciences, Inc. positions in Q3 2017 and 10 closed out, a net change of +2 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q3 2017 was Virtu Financial, an estimated $963K added.
  • The largest Genocea Biosciences, Inc. seller in Q3 2017 was Fidelity Investments, an estimated $16M sold.

Based on aggregated 13F filings for Q3 2017.